Development and Validation of a Risk Prediction Model for Acute Kidney Injury After the First Course of Cisplatin

PURPOSE: Cisplatin-associated acute kidney injury (C-AKI) is common. We sought to develop and validate a predictive model for C-AKI after the first course of cisplatin. METHODS: Clinical and demographic data were collected on patients who received cisplatin between 2000 and 2016 at two cancer center...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Clin Oncol
Egile Nagusiak: Motwani, Shveta S., McMahon, Gearoid M., Humphreys, Benjamin D., Partridge, Ann H., Waikar, Sushrut S., Curhan, Gary C.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Clinical Oncology 2018
Gaiak:
ORIGINAL REPORTS
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5946720/
https://ncbi.nlm.nih.gov/pubmed/29320311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.75.7161
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak